|Articles|October 3, 2015

Carolyn Presley on the Implications of Screening on Lung Cancer Care

Carolyn Presley discusses the implications of screening on diagnosis and treatment of lung cancer.

Carolyn Presley, clinical fellow, geriatric oncology, Yale Cancer Center, Robert Wood Johnson Clinical Scholar, discusses the implications of screening on diagnosis and treatment of lung cancer.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

How Does FDA-Approved Blenrep Treat Multiple Myeloma?

ByDr. Surbhi Sidana

October 24th 2025

Insights on Fertility and Survivorship in Hairy Cell Leukemia

ByDr. Alessandro Gozzetti

October 24th 2025

Rituxan Combinations Show Longer Remissions in Hairy Cell Leukemia

ByDr. Farhad Ravandi-Kashani

October 24th 2025

Insights Into Advancing Care and Research in Hairy Cell Leukemia

ByDr. Kerry A. Rogers

October 23rd 2025

Music Therapy Shown to Ease Cancer Survivors’ Anxiety

ByAlex Biese

October 23rd 2025

Carolyn Presley on the Implications of Screening on Lung Cancer Care

Newsletter

Related Content

How Does FDA-Approved Blenrep Treat Multiple Myeloma?

Insights on Fertility and Survivorship in Hairy Cell Leukemia

Rituxan Combinations Show Longer Remissions in Hairy Cell Leukemia

Insights Into Advancing Care and Research in Hairy Cell Leukemia

Music Therapy Shown to Ease Cancer Survivors’ Anxiety

Trending on CURE

Simple Ways for Patients With Cancer to Start Exercising

Anemia Management in Myelofibrosis: Survival and Quality of Life

Finding Credible Voices in the Lynch Syndrome Community

FDA Fast Tracks MT-125 for Glioblastoma

FDA Approves Revuforj for R/R NPM1-Mutant AML